Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy.
Nicholas BattBeverly RodriguesStephen BloomR SawhneyElena S GeorgeAlexander HodgeN VootukuruC McCraeSurbhi SoodStuart Keith RobertsA DevS BellA ThompsonM C RyanWilliam W KempP J GowSiddharth SoodA J NicollPublished in: Journal of gastroenterology and hepatology (2024)
Equal to ALD, MAFLD is now the most common underlying liver disease seen in HCC patients in Australia. Future HCC prevention screening and treatment strategies need to take this important group of patients into consideration.